US Stock MarketDetailed Quotes

RVPH Reviva Pharmaceuticals

Watchlist

0.969
+0.069+7.70%

Close Aug 23 16:00 ET

0.968
-0.001-0.08%

Post 20:02 ET

32.07MMarket Cap-734P/E (TTM)

Reviva Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-28.28%8.13M

13.42%7.92M

39.94%39.5M

-14.60%9.99M

200.57%10.71M

105.37%11.34M

-6.25%6.98M

179.37%28.23M

195.01%11.7M

43.85%3.56M

Selling and administrative expenses

-17.34%2.55M

42.50%2.14M

50.85%8.08M

2.42%1.51M

58.46%1.99M

206.37%3.08M

-7.38%1.5M

2.01%5.36M

13.41%1.48M

19.32%1.26M

-General and administrative expense

-17.34%2.55M

42.50%2.14M

50.85%8.08M

2.42%1.51M

58.46%1.99M

206.37%3.08M

-7.38%1.5M

2.01%5.36M

13.41%1.48M

19.32%1.26M

Research and development costs

-32.36%5.58M

5.47%5.78M

37.38%31.42M

-17.06%8.48M

278.03%8.72M

82.89%8.26M

-5.93%5.48M

371.39%22.87M

283.80%10.22M

62.01%2.31M

Operating profit

28.28%-8.13M

-13.42%-7.92M

-39.94%-39.5M

14.60%-9.99M

-200.57%-10.71M

-105.37%-11.34M

6.25%-6.98M

-179.37%-28.23M

-195.01%-11.7M

-43.85%-3.56M

Net non-operating interest income expense

-8.71%82.46K

21.71%169.61K

172.95%498.96K

55.60%177.52K

61.55%85.86K

553.32%90.32K

7,932.05%139.36K

7,672.58%182.8K

7,337.55%114.09K

9,816.64%53.15K

Non-operating interest income

-15.01%87.61K

17.74%173.1K

172.95%498.96K

37.70%157.11K

72.65%91.76K

645.61%103.08K

8,373.26%147.01K

--182.8K

--114.09K

--53.15K

Non-operating interest expense

-59.61%5.15K

-54.45%3.49K

----

--5.9K

--12.76K

--7.66K

----

--0

Other net income (expense)

142.67%194.65K

9,787.74%326.28K

-22.86%-239.22K

118.22%81.98K

4,062.46%144.27K

-365.42%-456.2K

-103.87%-3.37K

-112.24%-194.71K

-261.78%-449.99K

-101.82%-3.64K

Gain on sale of security

143.90%200.27K

4,000.10%456.18K

-22.86%-239.22K

114.46%66.76K

--139.08K

-356.25%-456.18K

-87.50%11.13K

-112.24%-194.71K

-266.00%-461.74K

----

Other non- operating income (expenses)

-29,484.21%-5.62K

-796.19%-129.89K

----

242.65%5.19K

99.69%-19

-636.86%-14.49K

----

---3.64K

Income before tax

32.89%-7.85M

-8.43%-7.43M

-38.96%-39.24M

19.14%-9.73M

-198.25%-10.48M

-119.38%-11.7M

6.96%-6.85M

-231.62%-28.24M

-226.52%-12.03M

-54.29%-3.51M

Income tax

14.75%7.39K

148.35%7.4K

-18.42%16.95K

-154.79%-4.58K

550.05%12.12K

-7.01%6.44K

-17.94%2.98K

246.05%20.78K

8.36K

-11.32%1.86K

Net income

32.87%-7.86M

-8.49%-7.43M

-38.92%-39.26M

19.24%-9.72M

-198.44%-10.49M

-119.22%-11.71M

6.97%-6.85M

-231.63%-28.26M

-226.75%-12.04M

-54.23%-3.52M

Net income continuous Operations

32.87%-7.86M

-8.49%-7.43M

-38.92%-39.26M

19.24%-9.72M

-198.44%-10.49M

-119.22%-11.71M

6.97%-6.85M

-231.63%-28.26M

-226.75%-12.04M

-54.23%-3.52M

Minority interest income

Net income attributable to the parent company

32.87%-7.86M

-8.49%-7.43M

-38.92%-39.26M

19.24%-9.72M

-198.44%-10.49M

-119.22%-11.71M

6.97%-6.85M

-231.63%-28.26M

-226.75%-12.04M

-54.23%-3.52M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

32.87%-7.86M

-8.49%-7.43M

-38.92%-39.26M

19.24%-9.72M

-198.44%-10.49M

-119.22%-11.71M

6.97%-6.85M

-231.63%-28.26M

-226.75%-12.04M

-54.23%-3.52M

Basic earnings per share

50.00%-0.26

19.35%-0.25

-13.79%-1.65

39.66%-0.35

-144.44%-0.44

-79.31%-0.52

22.50%-0.31

-150.00%-1.45

-163.64%-0.58

-50.00%-0.18

Diluted earnings per share

50.00%-0.26

19.35%-0.25

-13.79%-1.65

39.66%-0.35

-144.44%-0.44

-79.31%-0.52

22.50%-0.31

-150.00%-1.45

-163.64%-0.58

-50.00%-0.18

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-28.28%8.13M	13.42%7.92M	39.94%39.5M	-14.60%9.99M	200.57%10.71M	105.37%11.34M	-6.25%6.98M	179.37%28.23M	195.01%11.7M	43.85%3.56M
Selling and administrative expenses	-17.34%2.55M	42.50%2.14M	50.85%8.08M	2.42%1.51M	58.46%1.99M	206.37%3.08M	-7.38%1.5M	2.01%5.36M	13.41%1.48M	19.32%1.26M
-General and administrative expense	-17.34%2.55M	42.50%2.14M	50.85%8.08M	2.42%1.51M	58.46%1.99M	206.37%3.08M	-7.38%1.5M	2.01%5.36M	13.41%1.48M	19.32%1.26M
Research and development costs	-32.36%5.58M	5.47%5.78M	37.38%31.42M	-17.06%8.48M	278.03%8.72M	82.89%8.26M	-5.93%5.48M	371.39%22.87M	283.80%10.22M	62.01%2.31M
Operating profit	28.28%-8.13M	-13.42%-7.92M	-39.94%-39.5M	14.60%-9.99M	-200.57%-10.71M	-105.37%-11.34M	6.25%-6.98M	-179.37%-28.23M	-195.01%-11.7M	-43.85%-3.56M
Net non-operating interest income expense	-8.71%82.46K	21.71%169.61K	172.95%498.96K	55.60%177.52K	61.55%85.86K	553.32%90.32K	7,932.05%139.36K	7,672.58%182.8K	7,337.55%114.09K	9,816.64%53.15K
Non-operating interest income	-15.01%87.61K	17.74%173.1K	172.95%498.96K	37.70%157.11K	72.65%91.76K	645.61%103.08K	8,373.26%147.01K	--182.8K	--114.09K	--53.15K
Non-operating interest expense	-59.61%5.15K	-54.45%3.49K	----	----	--5.9K	--12.76K	--7.66K	----	----	--0
Other net income (expense)	142.67%194.65K	9,787.74%326.28K	-22.86%-239.22K	118.22%81.98K	4,062.46%144.27K	-365.42%-456.2K	-103.87%-3.37K	-112.24%-194.71K	-261.78%-449.99K	-101.82%-3.64K
Gain on sale of security	143.90%200.27K	4,000.10%456.18K	-22.86%-239.22K	114.46%66.76K	--139.08K	-356.25%-456.18K	-87.50%11.13K	-112.24%-194.71K	-266.00%-461.74K	----
Other non- operating income (expenses)	-29,484.21%-5.62K	-796.19%-129.89K	----	----	242.65%5.19K	99.69%-19	-636.86%-14.49K	----	----	---3.64K
Income before tax	32.89%-7.85M	-8.43%-7.43M	-38.96%-39.24M	19.14%-9.73M	-198.25%-10.48M	-119.38%-11.7M	6.96%-6.85M	-231.62%-28.24M	-226.52%-12.03M	-54.29%-3.51M
Income tax	14.75%7.39K	148.35%7.4K	-18.42%16.95K	-154.79%-4.58K	550.05%12.12K	-7.01%6.44K	-17.94%2.98K	246.05%20.78K	8.36K	-11.32%1.86K
Net income	32.87%-7.86M	-8.49%-7.43M	-38.92%-39.26M	19.24%-9.72M	-198.44%-10.49M	-119.22%-11.71M	6.97%-6.85M	-231.63%-28.26M	-226.75%-12.04M	-54.23%-3.52M
Net income continuous Operations	32.87%-7.86M	-8.49%-7.43M	-38.92%-39.26M	19.24%-9.72M	-198.44%-10.49M	-119.22%-11.71M	6.97%-6.85M	-231.63%-28.26M	-226.75%-12.04M	-54.23%-3.52M
Minority interest income
Net income attributable to the parent company	32.87%-7.86M	-8.49%-7.43M	-38.92%-39.26M	19.24%-9.72M	-198.44%-10.49M	-119.22%-11.71M	6.97%-6.85M	-231.63%-28.26M	-226.75%-12.04M	-54.23%-3.52M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	32.87%-7.86M	-8.49%-7.43M	-38.92%-39.26M	19.24%-9.72M	-198.44%-10.49M	-119.22%-11.71M	6.97%-6.85M	-231.63%-28.26M	-226.75%-12.04M	-54.23%-3.52M
Basic earnings per share	50.00%-0.26	19.35%-0.25	-13.79%-1.65	39.66%-0.35	-144.44%-0.44	-79.31%-0.52	22.50%-0.31	-150.00%-1.45	-163.64%-0.58	-50.00%-0.18
Diluted earnings per share	50.00%-0.26	19.35%-0.25	-13.79%-1.65	39.66%-0.35	-144.44%-0.44	-79.31%-0.52	22.50%-0.31	-150.00%-1.45	-163.64%-0.58	-50.00%-0.18
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall